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Introduction
The complex waveforms characteristic of beating cilia and
flagella result from spatial regulation of dynein activity along
the axonemal microtubules. Numerous studies have indicated
that the central apparatus plays a prominent role in spatially
regulating dynein activity on specific subsets of doublet
microtubules to modulate ciliary and flagellar waveform and
possibly beat frequency (for a review, see Smith and Yang,
2004). Importantly, organisms with mutations that result in the
failure of the entire central apparatus to assemble possess
flagella that are paralyzed (Witman et al., 1978; Dutcher et al.,
1984; Stannard et al., 2004). Flagellar motility can be restored
in central pair-less Chlamydomonas strains by the introduction
of a suppressor mutation (Huang et al., 1982), although the
motility of these suppressed strains is not entirely wild-type
(Brokaw et al., 1982). These suppressor mutations are typically
in components of the dynein arms or the dynein regulatory
complex (Huang et al., 1982; Piperno et al., 1992; Piperno et
al., 1994; Porter et al., 1992; Porter et al., 1994). Axonemes
isolated from central apparatus-defective mutants can be
reactivated using low ATP concentrations to produce modest
waveforms at very low beat frequency (Omoto et al., 1996). In
similar studies using low concentrations of ATP, various salts
and organic compounds, central pair-less axonemes were
reactivated with increased beat frequencies (~20 Hz) and larger
amplitude waveforms (Yagi and Kamiya, 2000).  Furthermore,
isolated axonemes from central pair-less mutants reactivated at
low ATP concentration also undergo modest waveform
conversion in response to changes in calcium concentration
(Wakabayashi et al., 1997; Frey et al., 1997). However, in all
these cases motility of the central pair-less axonemes is not
entirely the same as that of the wild type. Although the motility
of the double mutant strains and reactivated central pair-less
axonemes demonstrates that the central apparatus is not
absolutely required for motility or waveform conversion, these
studies imply a functional link between the central apparatus
and dynein arm activity to produce wild-type motility.
The central apparatus is an asymmetric structure comprising
two singlet microtubules, C1 and C2, that are structurally and
biochemically distinct. Studies of Chlamydomonas mutants
lacking specific central apparatus components have suggested
that the inherent asymmetry of this structure provides important
spatial cues for asymmetric regulation of dynein activity. For
example, the pf16 strain has flagella that are paralyzed or form
rudimentary bends that do not propagate. Flagella of pf16
mutants retain the C1 microtubule; yet, this central tubule is
completely destabilized and solubilized upon demembranation
to produce axonemes (Dutcher et al., 1984; Smith and Lefebvre,
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Studies of flagellar motility in Chlamydomonas mutants
lacking specific central apparatus components have
supported the hypothesis that the inherent asymmetry of
this structure provides important spatial cues for
asymmetric regulation of dynein activity. These studies
have also suggested that specific projections associated with
the C1 and C2 central tubules make unique contributions
to modulating motility; yet, we still do not know the
identities of most polypeptides associated with the central
tubules. To identify components of the C1a projection, we
took an immunoprecipitation approach using antibodies
generated against PF6. The pf6 mutant lacks the C1a
projection and possesses flagella that only twitch; calcium-
induced modulation of dynein activity on specific doublet
microtubules is also defective in pf6 axonemes. Our
antibodies specifically precipitated five polypeptides in
addition to PF6. Using mass spectrometry, we determined
the amino acid identities of these five polypeptides. Most
notably, the PF6-containing complex includes calmodulin.
Using antibodies generated against each precipitated
polypeptide, we confirmed that these polypeptides
comprise a single complex with PF6, and we identified
specific binding partners for each member of the complex.
The finding of a calmodulin-containing complex as an
asymmetrically assembled component of the central
apparatus implicates the central apparatus in calcium
modulation of flagellar waveform.
Supplementary material available online at
http://jcs.biologists.org/cgi/content/full/118/20/4655/DC1
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1996; Smith and Lefebvre, 2000). The flagella of the cpc1
mutant lack the C1b projection and beat with a wild-type
waveform, however, they beat at one-half the frequency of wild-
type flagella (Mitchell and Sale, 1999; Zhang and Mitchell,
2004). The pf6 mutant is defective in assembly of the C1a
projection (Dutcher et al., 1984; Rupp et al., 2001); these
flagella beat with a twitchy, uncoordinated waveform that is
ineffective in propelling the cell through liquid media.
Our previous structural and functional studies of dynein-
driven microtubule sliding provided evidence to indicate that
calcium control of waveform includes modulation of the
pattern of microtubule sliding between specific doublets
(Wargo et al., 2004). This control mechanism is disrupted in
certain mutants including the C1-defective mutant, pf6 (Wargo
et al., 2004). Our functional studies of dynein-driven
microtubule sliding in isolated axonemes indicate that
calmodulin and a calmodulin-dependent kinase may mediate
the calcium signal and that the central apparatus and radial
spokes are key components of the calcium signaling pathway
(Smith, 2002b). Taken together, the motility phenotypes of C1-
defective mutants combined with the results from our structural
and functional studies suggest that the C1 central tubule is
essential for wild-type motility and that each C1 projection
makes a unique contribution to modulation of flagellar motility.
Understanding the role of the C1 microtubule in flagellar
motility will require a complete molecular dissection of C1
components. To date, very few central apparatus polypeptides
have been characterized (for a review, see Smith and Yang,
2004). Using two-dimensional gel electrophoresis to compare
axonemes isolated from Chlamydomonas central apparatus-
defective mutants, at least 23 polypeptides are associated with
the central apparatus; 10 of these polypeptides are unique to
the C1 microtubule, three of which are components of the C1a
projection (Dutcher et al., 1984). Unfortunately, at the time
these studies were completed, mass spectrometry and a
complete Chlamydomonas genome sequence were not
available to determine the identities of these polypeptides.
By taking advantage of an insertional mutagenesis approach,
the amino acid sequences of several C1-associated
polypeptides have now been determined. The wild-type PF16
gene that encodes an armadillo repeat protein has been cloned
(Smith and Lefebvre, 1996), as has the CPC1 gene that encodes
a protein with an adenylate kinase domain (Zhang and
Mitchell, 2004). The predicted PF6 gene product is a large
(240 kDa), leucine-rich repeat protein that is predicted to form
a scaffold for the assembly of additional polypeptides that
comprise the C1a projection (Rupp et al., 2001). The PF6
protein sediments at 12S with at least four polypeptides that
are not present in pf6 axonemal extracts (Rupp et al., 2001).
These results indicate that PF6 is extracted from the axoneme
as a complex.
To specifically identify components of the C1a projection,
we generated antibodies against PF6 and used these antibodies
in immunoprecipitation experiments. The sequencing of the
Chlamydomonas reinhardtii genome combined with advances
in mass spectrometry provided the modern proteomics
approaches necessary to identify the polypeptides comprising
the C1 microtubule projections. Here, we report the identities
of five polypeptides (in addition to PF6) that are specifically
precipitated with anti-PF6 antibodies. Most notably, the PF6-
containing complex includes calmodulin. In addition, we have
determined direct binding partners for these polypeptides. The
finding of a calmodulin-containing complex as a component of
the central apparatus further implicates the central apparatus in
calcium modulation of flagellar waveform.
Materials and Methods
Strains and cell culture
Chlamydomonas reinhardtii strain A54-e18 (nit1-1, ac17, sr1, mt+)
has wild-type motility and was obtained from Paul Lefebvre
(University of Minnesota, St Paul, MN), the cpc1-2 strain was from
David Mitchell (SUNY, Syracuse, NY) and the pf30pf28 strain from
Winfield Sale (Emory University, Atlanta, GA). The strains pf16, pf6-
2, pf14 and pf18 were obtained from the Chlamydomonas Genetics
Center (Duke University). Cells were grown in constant light in TAP
media (Gorman and Levine, 1965). Chlamydomonas strains cited in
the text are listed in Table 1.
Axoneme isolation, protein extraction and sucrose gradient
fractionation
Flagella were severed from cell bodies by the dibucaine method
(Witman, 1986) and isolated by differential centrifugation in KLow
(10 mM HEPES, pH 7.4, 5 mM MgSO4, 1 mM DTT, 0.5 mM EDTA
and 50 mM potassium acetate). Axonemes were isolated by adding
NP-40 (Calbiochem, La Jolla, CA) to a final concentration of 0.5%
(w/v). The axonemes were pelleted and resuspended in KLow. Protein
concentration was determined using the Bradford assay (Bradford,
1976).
Axonemes were initially extracted in NaHigh (10 mM HEPES, pH
7.4, 5 mM MgSO4, 1 mM DTT, 0.5 mM EDTA, 50 mM potassium
acetate and 0.6 M NaCl) at a concentration of 6 mg/ml on ice for 20
minutes. The axonemes were pelleted, resuspended in NaHigh, and
immediately pelleted again. The supernatant was discarded and the
pellet was extracted with KI (10 mM HEPES, pH 7.4, 5 mM MgSO4,
1 mM DTT, 0.5 mM EDTA, 50 mM potassium acetate and 0.5 M KI)
at a concentration of 10-12 mg/ml for 20 minutes on ice. This extract
is referred to as the KI extract or high-salt extract. KI extracts were
dialyzed against NaLow buffer (the same composition as KLow
except with 75 mM NaCl and no potassium acetate) and clarified by
centrifugation at 12,000 g for 10 minutes. For some experiments the
clarified extracts were loaded onto 5-20% sucrose gradients and
subjected to ultracentrifugation at 35,000 rpm for 16 hours in an
SW41Ti rotor. Fractions (0.5 ml) were collected from the bottom of
the tube and prepared for SDS-PAGE.
Silver staining
For silver staining, gel plates were first rinsed in 50% nitric acid,
washed thoroughly in deionized water and rinsed with 95% ethanol.
After electrophoresis, gels were fixed in 50% methanol, 0.1% glacial
Journal of Cell Science 118 (20)
Table 1. Chlamydomonas strains used in this study
Strain Structural or motility defect
A54-e18 No axonemal structural defect/wild-type motility*
pf16 Defective in C1 stability in isolated axonemes/flagella paralyzed†
pf18 Lacks central apparatus/rigid paralyzed flagella‡
pf6-2 Lacks central apparatus C1a projection/flagella twitch†,§
cpc1-2 Lacks central apparatus C1b projection/reduced beat frequency¶
pf14 Lacks radial spokes/paralyzed flagella**
pf28pf30 Lacks outer dynein arms and inner dynein arms I1††,‡‡
*Smith and Lefebvre, 1996; †Dutcher et al., 1984; ‡Witman et al., 1972;
§Rupp et al., 2001; ¶Mitchell and Sale, 1999; **Piperno et al., 1977; ††Piperno
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acetic acid. Fixed gels were rinsed in deionized water for 8 minutes
and then shaken in 0.001 mM DTT for 25 minutes. The DTT solution
was replaced with a 0.1% aqueous silver nitrate solution. Following
a 25 minute incubation in silver nitrate solution, the gel was rinsed
quickly three times in deionized water and developed by the addition
of 0.02% (v/v) formaldehyde in 3% sodium carbonate. Color
development was halted by the addition of a one-quarter volume of 2
M citric acid.
Mass spectrometry, RNA isolation and RT-PCR
Gel bands were excised from Coomassie-stained gels. These bands
were analyzed by MALDI-TOF (matrix-assisted laser
desorption/ionization-time of flight) mass spectrometry with PSD
(post-source decay) conducted at the University of Massachusetts
Medical School (Worcester, MA) or LC/LC-ESI (liquid
chromatography/liquid chromatography-electrospray ionization)
mass spectrometry performed at Harvard Microchemistry and
Proteomics Facility (Cambridge, MA). Comparisons of peptide
masses with translated genomic or EST sequences were made using
the Sequest algorithm (Eng et al., 1994) and the Chlamydomonas
genome database (http://genome.jgi-psf.org/chlre2/chlre2.home.
html). The complete coding sequence for each polypeptide was
confirmed by RT-PCR.
RNA was isolated from wild-type Chlamydomonas reinhardtii cells
after pH shock-induced deflagellation (Wilkerson et al., 1994).
Poly(A) enrichment was performed using the Oligotex mRNA Kit
according to the manufacturer’s instructions (Qiagen, Valencia, CA).
Reverse transcription was performed using either Superscript II or
Superscript III according to the manufacturer’s instructions
(Invitrogen, Carlsbad, CA). Subsequent polymerase chain reactions
were performed using primers based on the known or predicted coding
regions as determined by EST, EST-contig or mass spectrometry data.
Construction of expression constructs, antibody production
and affinity purification
Polyclonal antibodies for PF6, PF6-IP2, -IP3 and -IP4 were generated
against bacterially expressed proteins in rabbits. For PF6, the genomic
DNA template encoding amino acids 199-283 was amplified by PCR.
For PF6-IP2, RT-PCR was used to generate a cDNA encoding amino
acids 4-143. For PF6-IP3, RT-PCR was used to generate a cDNA
encoding amino acids 2-267. For PF6-IP4, RT-PCR was used to
generate a cDNA encoding amino acids 24-144. In all cases, the
resulting PCR products were first ligated into the PCR2.1 vector using
the TOPO-TA cloning kit (Invitrogen). The PCR fragments were then
shuttled into the pET30 series of expression vectors (Novagen,
Madison, WI). Proper orientation and reading frame were confirmed
by DNA sequencing.
The above 6His-tagged constructs were transformed into BL21
E. coli cells containing the pLysS plasmid (Novagen). Expression was
induced by the addition of IPTG to a final concentration of 2 mM. For
antibody production, proteins were isolated and purified using the
manufacturer’s denaturing protocol. Peak fractions were dialyzed
against 4 M urea buffer (20 mM Tris-HCl, pH 7.9, 500 mM NaCl, 4
M urea) fixed with SDS sample buffer, and run on SDS-
polyacrylamide gels. Protein bands were excised from Coomassie-
stained gels and used for polyclonal antibody production in rabbits.
Rabbits were injected with 100-200 g of protein per injection, three
times for a standard protocol (PF6, PF6-IP2 and PF6-IP3) or four
times for an extended protocol (PF6-IP4). Handling of rabbits
including all injections and bleeds was conducted by Spring Valley
Laboratories (Woodbine, MD).
For affinity purification of antibodies PF6, PF6-IP2 and PF6-IP3
proteins were prepared from bacteria using the above protocol with
guanidine-HCl in place of urea. These protein fractions were
conjugated to Aminolink columns (Pierce Biotechnology, Rockford,
IL) according to the manufacturer’s protocol and used for affinity
purification. For affinity purification of PF6-IP4 antibodies, two
cysteine residues were engineered at the C-terminus of the expressed
PF6-IP4 protein. The protein resulting from this construct was purified
using the urea protocol and conjugated to Sulfolink resin (Pierce)
according to the manufacturer’s instructions.
Peptide antibodies were generated against PF6-IP1 and calmodulin.
For PF6-IP1 a peptide was synthesized corresponding to amino acids
791-808 (GRDEDEGGLLPVPEPWQGC). For anti-calmodulin
antibodies a peptide was synthesized representing the 17 C-terminal
amino acids. This peptide (RMMTSGATDDKDKKGHK) is unique
to Chlamydomonas calmodulin. For both the PF6-IP1 and calmodulin
peptides, the peptides were conjugated to KLH and injected into
rabbits for polyclonal antibody production. Peptide synthesis, peptide
conjugation and antibody production was performed at Spring Valley
Laboratories (Woodbine, MD). The resulting antibodies were affinity
purified using the appropriate peptide conjugated to a Sulfolink
column according to the manufacturer’s instructions (Pierce).
Western blotting
For western blots, proteins were transferred from gels to PVDF
membrane (Immobilon, Millipore, Billerica, MA). Blots were blocked
with 5% non-fat dry milk in TBS-T (150 mM NaCl, 20 mM Tris-HCl
pH 7.6, 0.1% Tween-20) and then incubated in primary antibody for
2 hours at room temperature. Affinity-purified antibodies were used
at the following dilutions: anti-PF6, 1:1000; anti-PF6-IP1, 1:3000;
anti-PF6-IP2, 1:500; anti-PF6-IP3, 1:2000; and anti-PF6-IP4, 1:100.
Blots were incubated in secondary antibody (HRP-conjugated donkey
anti-rabbit IgG (Amersham Biosciences Buckinghamshire, UK)
diluted 1:30,000 for 45 minutes at room temperature in TBS-T. ECL+
solutions were used as directed by the manufacturer (Amersham
Biosciences).
For western blots using anti-calmodulin antibodies, the proteins
were transferred to PVDF, the membranes rinsed quickly in TBS (150
mM NaCl, 20 mM Tris-HCl pH 7.6), and then fixed in TBS with 0.2%
glutaraldehyde for 30 minutes. The blot was rinsed for 5 minutes in
TBS and blocked for 1 hour in TBS with 5% BSA (Sigma-Aldrich,
St Louis, MO, regular fraction V, A-7906). After a brief rinse in TBS,
blots were incubated with anti-calmodulin antibody (1:7000) in TBS
with 1% BSA. After primary incubation, the blots were washed with
TBS-T (TBS with 0.05% Tween-20) and incubated with anti-rabbit
secondary antibody as above but in TBS-T with 1% BSA. Final
washes were carried out with TBS-T and ECL+ solutions were used
as directed.
Immunoprecipitation
For immunoprecipitations from extracts, the affinity-purified antibody
(30-70 g), sample (300-750 g dialyzed extract or undialyzed
extract where noted) and TBS-T150 (150 mM NaCl, 20 mM Tris-HCl,
pH 7.5) were added to ~70 l protein-A beads (Invitrogen) in a total
volume of 600 l. The sample was mixed for 1.5 hours at 4°C.
Samples were washed four times with 500 l TBS-T150 for 5 minutes
each. Unless noted, samples were prepared for SDS-PAGE by
addition of 100 l of 3 SDS sample buffer.
For immunoprecipitation using sucrose gradient fractions, 50-80
g antibody were used with 1200 l pooled sucrose gradient
fractions. Tween-20 was added to a final concentration of 0.05% (v/v).
The sample was mixed for 5-8 hours and washed with four 1 ml
volumes of TBS-T150.
Blot overlay
PF6-IP3::6His protein for blot overlays was isolated from bacteria
as described above, except no urea was used. Axonemal proteins were












overnight at 4°C. The PF6-IP3::6His protein was diluted to 4 g/ml
in TBS with 1% BSA and incubated with the blot for 2.5 hours at
room temperature. Overlayed protein was detected using S-protein
overlay with HRP-S-protein (Novagen) diluted 1:5000 in TBS-T. S-
protein was visualized with ECL+ according to the manufacturer’s
instructions.
Results
Immunoprecipitation of a PF6-containing complex
Based on the pf6 mutant phenotype, the C1a projection is
evidently important for ciliary and flagellar motility. The PF6
protein is large and predicted to form a scaffold that is required
for the assembly and/or stability of the C1a central pair
projection (Rupp et al., 2001). To begin defining the
polypeptides associated with the C1a projection, we generated
antibodies against PF6 and used them in immunoprecipitation
experiments. We expressed 289 amino acids at the C-terminus
of PF6 in bacteria, and then used the purified expressed protein
to generate polyclonal antibodies in rabbits (see Materials and
Methods). These antibodies are specific and recognize a
polypeptide of high molecular weight consistent with that of
PF6 in wild-type axonemes that is absent from axonemes
isolated from the pf6 mutant (Fig. 1A).
PF6 sediments at approximately 12S on sucrose gradients
indicating that it is extracted as a complex (Rupp et al., 2001).
To identify the components of this complex we used our anti-
PF6 antibodies to precipitate PF6 from dialyzed, axonemal salt
extracts. As a negative control, we also used axonemal extracts
isolated from the pf6 mutant. Our anti-PF6 antibodies
reproducibly precipitate five polypeptides in addition to PF6,
which we tentatively named PF6-IP1 to PF6-IP5 (Fig. 1B).
These polypeptides range in relative molecular mass from
approximately 75 kDa to 20 kDa and are not precipitated from
axonemal extracts isolated from the pf6 mutant.
Identification of polypeptides comprising the PF6
complex using mass spectroscopy
To determine the amino acid identities of the polypeptides
precipitated by our anti-PF6 antibodies, the bands
corresponding PF6-IP1, -IP2, -IP3 and -IP4 were excised from
polyacrylamide gels and subjected to mass spectrometry;
peptide masses were compared with those predicted from the
translated Chlamydomonas genome and EST databases (see
Materials and Methods). The results of these analyses are
shown in Table 2.
The complete amino acid sequence for PF6-IP1 was
determined from searches of the Chlamydomonas genomic
database using 43 peptide masses. In addition, two ESTs were
identified, one of which was in the 5-UTR, the other in the 3-
UTR. The PF6-IP1 gene is predicted to encode an 835 amino
acid protein with a calculated isoelectric point of 5.54 (v2;
scaffold 2: 712,757-717,357; GenBank accession DQ119666;
based on proximity to the GSP1 marker, the PF6-IP1 gene is
on LGII). In searches of translated databases, PF6-IP1 is most
similar (29% identity, 51% similarity over 102 amino acids) to
protein kinase A regulatory subunits within an RII-like leucine-
rich repeat region. However, PF6-IP1 lacks canonical cAMP
binding sites. The PF6-IP1 protein may correspond to the ~84
kDa protein that is reported to co-sediment with PF6 on
sucrose gradients (Rupp et al., 2001).
The amino acid sequence of PF6-IP2 was determined from
the Chlamydomonas genomic and EST databases using three
peptide masses (Table 2; peptides: DLSSAQLESIR,
RLQEEYEYEAAIPEEVK, and VMDWMLDSYYR). The
PF6-IP2 gene is predicted to encode a 306 amino acid protein
with a calculated isoelectric point of 5.63 (v2; scaffold 20:
996,339-997,738; GenBank accession DQ119665; based on
proximity to the TPX marker, the PF6-IP2 gene is on LGVI).
PF6-IP2 is 48% similar, 30% identical to the mouse protein
GM166 over a stretch of 207 amino acids. The PF6-IP2 protein
has a small, predicted coiled-coil region from amino acids 172
to 219, but contains no other predicted structural motifs. This
Journal of Cell Science 118 (20)
Fig. 1. (A,B) Western blots of axonemes and silver-stained gel of
immunoprecipitates. (A) Western blot of axonemes isolated from
wild-type (wt) and pf6-2 Chlamydomonas reinhardtii cells probed
with our anti-PF6 antibodies. A band with a molecular weight
consistent with that of PF6 is present in wild-type axonemes and
absent in pf6-2 axonemes. (B) Silver-stained gel of
immunoprecipitates obtained from wild-type (wt) and pf6-2
axonemal extracts using our anti-PF6 antibodies. In wild-type
axonemal extracts, five polypeptides in addition to PF6 are
specifically precipitated using anti-PF6 antibodies. These
polypeptides are not precipitated in pf6-2 axonemal extracts. The
precipitating immunoglobulin heavy and light chains are labeled HC
and LC, respectively.
Table 2. Summary of mass spectrometry data and similarity searches
IP band  kDa Peptides BLAST results (most similar to) Cilia proteome* Proposed name
PF6-IP1   86 45 T. brucei PKA regulatory subunit (E=4e-04) FAP 101 C1a-86
PF6-IP2   34 3 Unnamed T. nigroviridus protein (E=4e-14) FAP119 C1a-34
PF6-IP3   32 1 Gm166 protein from M. muscalis (E=2e-06) FAP114 C1a-32
PF6-IP4   18 1 T. brucei hypothetical protein (E=2e-27) FAP227 C1a-18











4659Flagellar central apparatus complex
protein may be identical to the ~43 kDa protein reported to co-
sediment with PF6 on sucrose gradients (Rupp et al., 2001).
The amino acid sequence of the PF6-IP3 protein was
determined from the Chlamydomonas genomic and EST
databases using one peptide mass (Table 2; peptide:
KPATLEEAIEHLVATR). Numerous overlapping ESTs
comprised the complete coding sequence for PF6-IP3 (Contig
20021010.4549.3). The PF6-IP3 gene encodes a predicted 286
amino acid protein with a calculated isoelectric point of 5.56
(v2; scaffold 8: 1,039,925-1,043,440; GenBank accession
DQ119664; telomeric to YPTC4 on LGII). Like PF6-IP2,
PF6-IP3 is similar to the Gm166 protein from mouse brain
with 47% similarity, 26% identity over a stretch of 129 amino
acids. In addition, proteins with weak similarity are found in
Rattus norvegicus, Tetraodon nigroviridis, Canis familiaris
and Gallus gallus databases. Although there are no obvious
functional domains in PF6-IP3, the protein contains two
predicted coiled-coil regions that are well supported by the
Coils (Lupas et al., 1991) and the Paircoil (Berger et al., 1995)
algorithms. Interestingly, when sequence comparisons are
conducted using the pair-wise blastp algorithm (Tatusova and
Madden, 1999), the 150 N-terminal amino acids of PF6-IP2
and PF6-IP3 align with 22% identity and 41% similarity
(supplementary material Fig. S1). If the alignment is
conducted without the low complexity filter, these two
proteins align with 26% identity and 42% similarity along
their entire length. This slight difference is due to the
significant number of alanine residues in the carboxyl half of
both proteins.
The amino acid sequence of the PF6-IP4 protein was
determined from the Chlamydomonas genomic database using
one peptide mass (Table 2; peptide: KFYYPSGAIYEGQWK).
Predicted intron and exon boundaries were confirmed by RT-
PCR (see Materials and Methods). The PF6-IP4 cDNA
encodes a predicted 173 amino acid protein with a calculated
isoelectric point of 5.70 (v2; scaffold 1:101,203-103,216;
coding sequence GenBank accession DQ119663; centromeric
to the S926 marker from LGXIX) (Kathir et al., 2003).
Searches of translated databases reveal similar proteins in the
flagellated organisms Leishmania major, Trypanosoma brucei
and Cyprinus carpio. All these proteins contain MORN
(membrane occupation and recognition nexus) domains, with
similarity to MORN domain-containing phosphatidylinositol
4-phosphate-5-kinases in vascular plants. Based on molecular
mass, predicted isoelectric point and its absence in pf6
axonemes, the PF6-IP4 protein may correspond to CP18
described previously (Dutcher et al., 1984).
PF6-IP5 is calmodulin
Axonemal calmodulin is extractable and sediments in three
distinct peaks of approximately 21S, 12S and 6S on sucrose
gradients (Yang et al., 2001). The 21S peak corresponds to
calmodulin associated with the radial spokes. The 12S peak of
calmodulin is thought to be associated with the central
apparatus (P. Yang, Marquette University, Milwaukee, WI,
personal communication). We generated anti-calmodulin
antibodies that recognize the unique C-terminus of
Chlamydomonas calmodulin and that are of higher affinity than
commercially available anti-calmodulin antibodies (see
Materials and Methods). Using our anti-calmodulin antibodies
we probed sucrose gradient fractions of axonemal extracts
prepared from the wild type and central apparatus-defective
mutants. The 12S peak of calmodulin was not present or
extremely reduced in extracts isolated from pf18 and pf16 (Fig.
2A) suggesting the calmodulin is associated with the C1
microtubule of the central apparatus. Based on this observation
and the apparent molecular weight of PF6-IP5 we suspected
that this polypeptide was calmodulin. Western blots of our PF6
immunoprecipitates probed with our anti-calmodulin
antibodies confirmed that PF6-IP5 is in fact calmodulin (Fig.
2B).
PF6-IP1, IP2, IP3, IP4 and calmodulin are components
of a single PF6-containing complex that localizes to the
C1a projection
To confirm that the proteins we precipitated correspond to a
PF6-containing complex that localizes to the C1a projection,
we bacterially expressed PF6-IP1, -IP2, -IP3 and -IP4 and used
the purified proteins for polyclonal antibody production in
rabbits. Each of these antibodies is specific and recognizes a
protein of the correct molecular weight on blots of wild-type
axonemes (Fig. 3A,B). The failure of PF6-IP1, -IP2, -IP3 and
-IP4 to assemble in pf6 mutant axonemes strongly suggests
their localization to the C1a projection.
Western blots using our anti-PF6, PF6-IP1, -IP2, -IP3, -IP4
and calmodulin antibodies revealed that each of these
polypeptides is precipitated using our anti-PF6 antibodies (Fig.
4). To determine if PF6 is present in multiple complexes
containing subsets of these five polypeptides or if the PF6
immunoprecipitate represents one large complex, we then used
antibodies generated against PF6-IP1, -IP2, -IP3, -IP4 and
Fig. 2. (A,B) Western blots of sucrose gradient fractions and
immunoprecipitates. (A) Western blots of axonemal extracts obtained
from wild-type, pf18 and pf16 axonemes fractionated on 5-20%
sucrose gradients. Blots were probed with our anti-calmodulin
antibodies. Calmodulin sediments in three distinct peaks. The 12S
peak of calmodulin is lacking or severely reduced in central pair-
defective mutants. (B) Western blots of immunoprecipitates obtained
from wild-type (wt) and pf6-2 axonemal extracts using our anti-PF6
antibodies. The blot was probed with anti-calmodulin antibodies.













calmodulin in reciprocal immunoprecipitation experiments.
The antibodies generated against PF6-IP2 and PF6-IP4
appeared to only recognize denatured protein and were
therefore not useful for immunoprecipitation. However, the
PF6-IP1 and PF6-IP3 antibodies precipitate all six members of
the PF6-containing complex as evidenced by both silver-
stained gels and western blot (Fig. 4).
Interestingly, our anti-calmodulin antibodies precipitate all
six members of this complex as well as several other
polypeptides (Fig. 4). A subset of these polypeptides are
precipitated from wild-type axonemal extracts, but not from
axonemal extracts isolated from the radial spokeless mutant,
pf14 (Fig. 4, dots). Therefore, these polypeptides probably
represent radial spoke components that are associated with
calmodulin (see Yang et al., 2001). Three additional
polypeptides (Fig. 4, dashed lines) that are present in radial
spoke-defective mutants are also precipitated using our anti-
calmodulin antibodies. However, as these polypeptides are not
precipitated by any of our other antibodies and are present in
all central apparatus-defective mutants including pf6 (not
shown), they are probably not components of the PF6-
containing complex. The identities and localization of these
components will be described in a subsequent publication.
Our initial immunoprecipitation experiments were
performed using KI axonemal extracts that were dialyzed prior
to precipitation. To rule out the possibility that dialysis restores
interactions that do not normally occur in the axoneme, we first
extracted wild-type and pf14 axonemes with only 0.6 M NaCl
and performed immunoprecipitation experiments on these
undialyzed extracts. Although NaCl extracts significantly less
protein from the axonemal microtubules compared to KI, our
anti-PF6, anti-PF6-IP1, and anti-PF6-IP3 antibodies
precipitated all members of the PF6 complex from extracts
prepared from both wild-type and pf14 axonemes (data not
shown). In a second experiment, we precipitated PF6 from the
membrane-matrix fraction isolated from pf16 axonemes. In
pf16 axonemes, the C1 microtubule assembles but is unstable;
upon demembranation with non-ionic detergent, the C1
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Fig. 3. Western blots of axonemes isolated from wild-type (wt) and
pf6-2 cells probed with antibodies generated against PF6-IP1, -IP2,
-IP3, -IP4 and calmodulin (CaM). (A) Blots of 4-16% gradient
polyacrylamide gels. (B) Blots of 15% polyacrylamide gels. The
anti-PF6-IP4 antibody recognizes a polypeptide of the correct size
(asterisk). With the exception of calmodulin, each of the proteins is
missing from pf6-2 axonemes.
Fig. 4. (A,B) Silver-stained gel and corresponding western blots of
immunoprecipitates. (A) Silver-stained gel of immunoprecipitation
experiments. Axonemal extracts were prepared from wild-type (wt)
and radial spoke-defective (pf14) strains. The antibody used for
precipitation is noted at the top of each lane. Our anti-calmodulin
antibodies precipitate all six members of the PF6-containing complex
as well as several other polypeptides (dots and dashed lines). A
subset of these polypeptides is precipitated from wild-type axonemal
extracts, but not from axonemal extracts isolated from the radial
spokeless mutant, pf14 (dots). Therefore, these polypeptides
probably represent radial spoke components that are associated with
calmodulin. Three additional polypeptides (dashed lines) that are
present in radial spoke-defective mutants are also precipitated using
our anti-calmodulin antibodies. As these polypeptides were not
precipitated by any of our other antibodies, they are probably not
components of the PF6-containing complex. The precipitating
immunoglobulin heavy and light chains are labeled HC and LC,
respectively. (B) Corresponding western blots for
immunoprecipitations performed from wild-type extracts. The blots
were probed with the antibodies against the proteins listed to the
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microtubule is solubilized. Our anti-PF6 antibodies
precipitated all members of the PF6-containing complex from
the pf16 membrane-matrix fraction (data not shown). These
experiments provide additional confirmation that we have
identified all members of the PF6 complex and that their
interactions are not dependent on high-salt extraction and
subsequent dialysis.
PF6 sediments at approximately 12S on sucrose gradients
(Rupp et al., 2001) and as indicated in Fig. 2, calmodulin also
sediments at 12S. Therefore, we predicted that PF6-IP1, -IP2,
-IP3 and -IP4 would co-sediment at 12S. Western blots of
dialyzed wild-type axonemal extracts fractionated on sucrose
gradients revealed that these four polypeptides sediment in two
peaks, 12S and approximately 6S (Fig. 5). We suspected that
the 6S peak represented either subunits of the larger 12S peak
that had dissociated, or subunits of the 12S complex that failed
to re-associate during dialysis of the high-salt extract.
Distinguishing between these possibilities provided an
opportunity to begin determining precise binding partners for
each of the complex components.
Direct interactions between components of the PF6
complex
To determine the composition of the 12S and 6S sedimenting
complexes, we performed immunoprecipitation experiments
from corresponding sucrose gradient fractions using our anti-
PF6 antibodies. The anti-PF6 antibodies precipitate PF6, PF6-
IP1, -IP2, -IP3 and -IP4 and calmodulin from the 12S fraction,
however, only PF6 is precipitated from the 6S fraction (Fig.
6A,B, left panel). We also performed immunoprecipitation
experiments from the 12S and 6S fractions using our anti-PF6-
IP1 and anti-PF6-IP3 antibodies. The anti-PF6-IP1 antibodies
precipitate PF6, PF6-IP1, -IP2, -IP3 and -IP4 as well as
calmodulin from the 12S fraction; however, only PF6-IP1 and
small amounts of PF6 and calmodulin were precipitated from
the 6S fraction. Using our anti-PF6-IP3 antibodies PF6, PF6-
IP1, -IP2, -IP3 and -IP4 were immunoprecipitated from the 12S
fractions (Fig. 6A,B, right panel). However, in experiments
using the 6S fractions, only PF6-IP2, -IP3 and -IP4 were
detected in the anti-PF6-IP3 immunoprecipitates (Fig. 6A,B,
right panel); there is no detectable PF6, PF6-IP1, or calmodulin
precipitated from this fraction. These results provide further
confirmation that these five components form a single complex
that includes PF6 and calmodulin and suggest that PF6-IP2,
-IP3 and -IP4 interact with each other.
To determine if dialysis is required to form the 12S complex
and further define binding partners for specific polypeptides,
we conducted immunoprecipitation experiments from
undialyzed, high-salt extracts (Fig. 7). Under high-salt
conditions, our anti-PF6 antibodies precipitate PF6 and
minimal amounts of PF6-IP2, -IP3 and calmodulin. Both our
anti-PF6-IP1 and anti-calmodulin antibodies precipitate both
PF6-IP1 and calmodulin, suggesting that PF6-IP1 and
calmodulin directly interact. Our anti-PF6-IP3 antibodies
precipitate PF6-IP2, PF6-IP3 and PF6-IP4 and very minimal
amounts of PF6. These studies provide additional evidence that
PF6-IP2, -IP3 and -IP4 directly interact and suggest that the
12S complex reforms during dialysis.
Based on our precipitation results using undialyzed high-salt
extracts, we suspected that the 12S complex only partially
reforms upon dialysis resulting in complexes that sediment at
6S as well as 12S. To test this hypothesis, we fractionated non-
dialyzed axonemal extracts on high-salt sucrose gradients.
PF6, PF6-IP1, -IP2, -IP3, -IP4 and calmodulin all sediment at
6S with no detectable 12S peak (Fig. 8). These results support
the hypothesis that the 12S PF6-containing complex requires
dialysis to reassemble.
Our immunoprecipitation experiments suggest that PF6-IP3
Fig. 5. Western blots of axonemal extracts obtained from wild-type
axonemes fractionated on 5-20% sucrose gradients. Blots were
probed with antibodies generated against the proteins noted to the
right of each panel. PF6 and PF6-IP1, -IP2, -IP3 and -IP4 sediment
in two peaks.
Fig. 6. (A,B) Silver-stained gels and corresponding western blots of
immunoprecipitates. (A) Silver-stained gels of immunoprecipitation
experiments performed from pooled sucrose gradient fractions. The
precipitating antibodies (Ab) and the fractions (F) used for each
experiment are noted at the top of the lanes. The panel on the left is
an 8% polyacrylamide gel whereas the panel on the right is a 12%
polyacrylamide gel. The precipitating immunoglobulin heavy and
light chains are labeled HC and LC, respectively. (B) Corresponding
western blots using our anti-calmodulin and anti-PF6-IP4 antibodies.
All six polypeptides in the PF6 complex precipitate from the 12S













interacts with PF6-IP2 and PF6-IP4. To determine whether PF6-
IP3 directly interacts with PF-IP2 or PF6-IP4 we used a blot
overlay approach. Soluble, bacterially expressed PF6-
IP3::6His protein was used to probe a nitrocellulose blot of
axonemal protein samples from a variety of strains. PF6-IP3
specifically interacted with a band of ~37 kDa that was absent
from pf6 axonemes and greatly reduced in pf16 and pf18
axonemes (Fig. 9). The molecular weight of this polypeptide and
its absence in pf6 axonemes strongly suggests that it is PF6-IP2.
Discussion
Phenotypic analyses of C1-defective mutants (e.g., Dutcher et
al., 1984; Mitchell and Sale, 1999) as well as recent structural
and functional studies (Smith, 2002a; Smith, 2002b; Wargo
and Smith, 2003; Wargo et al., 2004) have provided ample
evidence to indicate that the C1 microtubule plays a role in
regulation of motility. In addition, each C1 projection appears
to make a unique contribution to modulation of flagellar
motility. For example, we have shown that modulation of
dynein activity on specific subsets of doublet microtubules in
response to changes in calcium concentration is defective in
pf6 axonemes (Wargo et al., 2004). It is not yet clear whether
this regulation involves structural or biochemical modification
of axonemal components; these two possibilities are not
mutually exclusive. In either event, understanding the
molecular mechanism of this regulation will require
identification of the polypeptides that comprise the C1
projections. We have taken an immunoprecipitation approach
to begin defining the polypeptides comprising the C1a
projection by using antibodies generated against a polypeptide
(PF6) required for assembly of the C1a projection. We have
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Fig. 7. (A,B) Silver-stained gels and corresponding western blots of
immunoprecipitates. (A) Silver-stained gel of immunoprecipitation
experiments using undialyzed, high-salt axonemal extracts obtained
from wild-type flagella. The precipitating antibody is indicated at the
top of each lane. The immunoglobulin heavy and light chains are
labeled HC and LC, respectively. (B) Corresponding western blots
from immunoprecipitation experiments. The blots were probed with
the antibodies indicated to the right of each panel. In high-salt
conditions, PF6-IP1 and calmodulin co-precipitate, and PF6-IP2,
-IP3 and -IP4 co-precipitate. Only very minimal amounts of complex
components precipitate with PF6.
Fig. 8. Western blots of undialyzed high-salt axonemal extracts
obtained from wild-type axonemes fractionated on 5-20% sucrose
gradients. Blots were probed with antibodies generated against the
proteins noted to the right of each panel. Under high-salt conditions,
all six members of the PF6 complex sediment at 6S.
Fig. 9. Western blot of gel overlay assay. Axonemes from wild-type
(wt) and mutant axonemes were subjected to SDS-PAGE and
transferred to nitrocellulose membrane. The blot was then incubated
with bacterially expressed PF6-IP3. The bound PF6-IP3 was detected
using S-protein overlay (see Materials and Methods). PF6-IP3 binds
to a polypeptide of molecular weight consistent with that of PF6-IP2
(asterisk). This polypeptide is absent in axonemes isolated from pf6,
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identified five polypeptides that form a complex with PF6, one
of which is calmodulin, and have determined direct binding
partners for these polypeptides.
We tentatively named the four polypeptides (not including
PF6 or calmodulin) that precipitated with our anti-PF6
antibodies, PF6-IP1, PF6-IP2, PF6-IP3 and PF6-IP4. All of
these polypeptides have been identified in the recently reported
Chlamydomonas flagellar proteome (see Table 2) (Pazour et
al., 2005). Our conclusions that these polypeptides form a
single complex with PF6 and calmodulin and localize to the
C1a projection are based on the following results. First, all six
polypeptides precipitate with our anti-PF6, anti-PF6-IP1, anti-
PF6-IP3 and anti-calmodulin antibodies. Although our anti-
calmodulin antibodies precipitate additional polypeptides,
precipitation experiments using mutant axonemes indicate that
these polypeptides localize to other axonemal structures.
Second, all six polypeptides cosediment at 12S on sucrose
gradients. A subset of components sediments at 6S; however,
precipitation experiments of undialyzed KI axonemal extracts
indicate that this 6S fraction probably represents complexes
that were disrupted during high-salt extraction and not
reformed during dialysis. This conclusion is also supported by
data from immunoprecipitation experiments using either
undialyzed NaCl extracts from wild-type axonemes or
detergent solubilized C1 components isolated from pf16
axonemes. Finally, with the exception of calmodulin, all of
these polypeptides are lacking from pf6 mutant axonemes. As
noted above, calmodulin is present in other structures in the
axoneme including the radial spokes (Yang et al., 2001). Based
on these combined results, we propose to give PF6-IP1, -IP2,
-IP3 and -IP4 the following names, C1a-86, C1a-34, C1a-32
and C1a-18, based on their calculated molecular weight and
apparent localization within the axoneme (Table 2). We have
obtained no data to support the hypothesis that PF6 interacts
with either PF16 or PF20 (see Zhang et al., 2002; Zhang et al.,
2005).
Although none of these polypeptides appear to be the
Chlamydomonas homologues of proteins with known function,
PF6-IP1, -IP3 and -IP4 contain previously characterized
protein-protein interaction motifs. The PF6-IP1 protein
contains leucine-rich repeats that are most similar to those from
PKA regulatory proteins. PF6-IP3 has two predicted coiled-
coil domains, and PF6-IP4 has three MORN domains.
The lack of an intact regulatory RII dimerization domain
does not preclude a role for PF6-IP1 as a PKA regulatory
subunit, as PKAs of both Paramecium and Dictyostelium
have subunits that do not have RII domains (Mutzel et al.,
1987; Carlson and Nelson, 1996). In addition, the leucine-
rich repeat region of PF6-IP1 aligns with the CAP_ED
domain of the Trypanosoma predicted regulatory subunit
(29% identity, 51% similarity). The CAP_ED domain
(CD00038) (Marchler-Bauer et al., 2005) is a conserved set
of amino acids that binds cyclic nucleotides or assists in the
binding of flavin groups; the predicted trypanosome
CAP_ED-containing protein has been shown to stimulate the
PKA catalytic subunit in a cAMP-dependent manner
(Seebeck et al., 2001). The similarity of PF6-IP1 and the
trypanosome CAP_ED suggests that PF6-IP1 may function
as an unconventional regulatory subunit.
The MORN domains found in PF6-IP4 were first described
to be required for plasma membrane binding in human
junctophilins (Takeshima et al., 2000). Recently, the amino
acid sequences of two polypeptides associated with the radial
spoke head were determined and found to have repeated
MORN motifs (P. Yang, personal communication). The
presence of multiple MORN motif-containing polypeptides
in the axonemes suggests their importance in assembly and/or
function of the organelle. One hypothesis is that the MORN
motifs function like the junctophilin MORN motifs and allow
association with the flagellar membrane. This association
may be required for correct assembly of axonemal
components by intraflagellar transport. Alternatively, the
MORN motif may represent a novel folding motif used to
generate a characteristic structure and used for a variety of
functions.
We have also begun to determine interactions between
individual components of the complex. A summary diagram
illustrating these complexes and their interactors is shown in
Fig. 10. Based on sucrose gradient sedimentation and
immunoprecipitation using undialyzed KI high-salt extracts,
PF6-IP1 interacts with calmodulin. PF6-IP2, PF6-IP3 and PF6-
IP4 appear to form a sub-complex in which PF6-IP3 directly
interacts with PF6-IP4. Both the PF6-IP1/calmodulin and the
PF6-IP2/-IP3/-IP4 sub-complexes are stable in high salt
concentrations. However, the 12S complex contains all six
polypeptides requires dialysis into low salt concentrations to
reform. Although it is possible that dialysis induces formation
of a large complex that does not naturally occur in the
axoneme, we think this possibility is unlikely. All six
polypeptides precipitate from undialyzed NaCl extracts
isolated from wild-type axonemes, all six polypeptides
precipitate from the membrane matrix fraction isolated from
pf16 axonemes, and all six polypeptides are absent from pf6
mutant axonemes, indicating that PF6 is required for their
assembly.
Important questions we have yet to consider are: have we
identified all of the polypeptides that correspond to the C1a
Fig. 10. Models of C1a components and their interactions based on













projection and what is the relative stoichiometry of the
constituent polypeptides of this complex? The C1a projection
is approximately 20 nm in length and 4 nm in width. The PF6
protein has a molecular weight of 237 kDa. Based on the
assumption that the partial specific volume for soluble,
globular proteins is approximately 0.73 cm3/g, PF6 would
occupy a volume of 287 nm3. If we assume that PF6 is present
in a more extended rectangular form, this volume could be
occupied by a rectangular block 4 nm in both length and width
and 18 nm in height. These dimensions are not significantly
different from that of the C1a projection. When the volumes
of the polypeptides we identified as components of the PF6
complex are considered, it seems reasonable to conclude that
these polypeptides may form the C1a projection in its entirety.
We have performed two-dimensional gel electrophoresis of our
precipitated proteins to rule out the possibility that additional
components are obscured by the antibody heavy and light
chains (not shown). As far as we can ascertain given that our
antibodies are polyclonal, we have identified all of the
members of the precipitated complex. However, we cannot rule
out the possibility that there may be additional minor
components that are dissociated and are not precipitated by the
PF6 antibodies.
We have attempted microtubule binding experiments using
both axonemal extracts and 12S sucrose gradient fractions to
investigate whether this complex can bind to microtubules
assembled from purified tubulin in vitro. So far, this complex
has failed to sediment with microtubules. These results may
indicate that an as yet unidentified adaptor complex is
required for binding these C1a projection components to
microtubules. Alternatively, it is possible that this complex
must assemble concurrently with microtubule assembly.
However, as dikaryon rescue experiments with pf6 mutants
are successful (Dutcher et al., 1984), this possibility seems
unlikely.
Another important question to answer is, what are the
precise functions of the individual polypeptides we identified?
With the exception of pf6, the genes encoding the members of
this complex do not map to previously identified mutations. To
determine if any one polypeptide plays a role in regulating
motility we are pursuing RNAi knockdown of transcript levels.
We predict that the mutant motility phenotype will not be as
severe as that of pf6 but not wild-type. So far, our attempts at
reducing expression levels of PF6-IP2 and -IP3 have been
unsuccessful. We are currently generating constructs for PF6-
IP1 and -IP4 for RNAi silencing.
Our previous studies have suggested a possible role for the
C1a projection in calcium regulation of flagellar motility
(Smith, 2002b; Wargo et al., 2004). The finding that
calmodulin, an important calcium sensor, is a component of the
C1a complex is an exciting result and further implicates this
structure in calcium modulation of motility. This complex may
regulate the detection and/or transmission of a calcium
regulatory signal to the radial spokes. As calmodulin plays
many important roles in cell function, it is not feasible to knock
down calmodulin expression to ascertain its role in flagellar
motility. However, based on our finding that the central
apparatus calmodulin binds to PF6-IP1, knockdown of PF6-
IP1 may provide clues as to the role of central apparatus
associated calmodulin in calcium detection and waveform
modulation. 
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